Abstract
Kimberly Horstman, Ha Nguyen
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation
10.1542/peds.2022-058859 · 2022
AAP 2022 hyperbilirubinemia management calculator
2012
Births in the United States
2024
Impact of the 2022 AAP guidelines on neonatal hyperbilirubinemia admissions: a PHIS study
10.1542/hpeds.2024-008205 · 2025
Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns
10.1542/peds.2014-0987 · 2014
Bilirubin measurement and phototherapy use after the AAP 2022 newborn hyperbilirubinemia guideline
10.1542/peds.2023-063323 · 2024
Serum albumin assessment in neonatal jaundice: impact on phototherapy decision-making
10.1542/hpeds.2024-007980 · 2025
Importance of direct antiglobulin test (DAT) in cord blood: causes of DAT (+) in a cohort study
10.1016/j.pedneo.2014.11.005 · 2015
No additional external references are available.